openPR Logo
Press release

What are the differences between ACEA A3/B4 and C2 C3?

12-17-2024 11:18 PM CET | Associations & Organizations

Press release from: ABNewswire

A3/B4 refers to the quality grade of engine oil and complies with the A3/B4 quality grade in the ACEA (European Automobile Manufacturers Association) classification. Grades starting with "A" represent the specifications for gasoline engine oils. Currently, they are divided into five grades: A1, A2, A3, A4, and A5. Grades starting with "B" represent the specifications for light-duty diesel engine oils and are currently divided into five grades: B1, B2, B3, B4, and B5.

The ACEA standards are upgraded approximately every two years. The latest standards are the 2016 version 0 (in 2016), version 1 (in 2017), and version 2 (in 2018). Correspondingly, the certification standards of various automobile manufacturers are also upgraded year by year. For the same Volkswagen VW 50200 certification and Mercedes-Benz MB 229.5 certification, it is also necessary to distinguish whether they have been upgraded to the latest standards. Those that are always willing to upgrade demonstrate self-discipline and the pursuit of quality and performance. Generally speaking, it is already good if engine oil can meet the certifications, and it may not always be willing to keep up with the upgrades.

ACEA C series are used for gasoline engines and light-duty diesel engines with after-treatment systems. Among them, ACEA C1 and C4 are low SAPS (Sulfated Ash, Phosphorus, and Sulfur) engine oil standards, while ACEA C2, C3, and C5 are medium SAPS engine oil standards.

The common point between the C3 and A3/B4 standards is that the High Temperature High Shear (HTHS) value is greater than or equal to 3.5. The main difference is that one is of medium ash content while the other is of high ash content. That is to say, there cannot be an oil that meets both A3/B4 and C3 at the same time.

The core difference between the C3 and A3/B4 series lies in the element limits, mainly sulfur and phosphorus. They can cause the premature failure of the three-way catalytic converter, and excessive ash content can cause the failure of the DPF (Diesel Particulate Filter) in diesel cars. Therefore, European car manufacturers have set limits on these three indicators simultaneously, giving rise to the new C standards. The C series has been introduced for nearly 20 years. There are a large number of diesel cars in the European market, so this standard is highly targeted. However, in China, this may not be the case. 95% of passenger cars in China are gasoline-powered vehicles without DPFs, so the ash content limit is not of great significance. If your car doesn't care much about the three-way catalytic converter, you can completely use A3/B4 oil. Gasoline cars that meet China's National Standard V and below have no major problems using A3/B4 oil.

However, due to the introduction of GPF (Gasoline Particulate Filter) in China's National Standard VI vehicles, the high ash content of A3/B4 oil has a significant impact, and the oil quality has thus been forced to upgrade to the C standards. There is another difference between A3/B4 and C3: that is TBN (Total Base Number). A3/B4 requires TBN > 10, while the C series only requires TBN > 6.0. There are two reasons for this. First, the decrease in ash content leads to a decrease in the base number, which can no longer be as high as before. Second, with the improvement of fuel quality, TBN doesn't need to be that high anymore. In the past, when the fuel quality in China was poor, the high TBN of A3/B4 was very valuable. Now that the fuel quality has improved and the sulfur content has decreased, its significance is not as great. Of course, in regions with poor fuel quality, the performance of A3/B4 is still better than that of C3. The third difference lies in fuel economy. The A3/B4 standard has no requirements for fuel economy, while engine oils that meet both the ACEA C3 and API SP standards have strict requirements for fuel economy, camshaft protection, timing chain protection, and resistance to low-speed pre-ignition. To sum up, the most significant difference between A3/B4 and C3 is that C3 is a product with medium and low SAPS (ash content). In terms of other parameters, C3 can completely cover the applications of A3/B4 and meets the Euro VI and China's National Standard VI emission standards.

Media Contact
Company Name: SHANGHAI JOCEN INDUSTRY CO., LTD.
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=what-are-the-differences-between-acea-a3b4-and-c2-c3]
Country: China
Website: https://www.jocentools.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What are the differences between ACEA A3/B4 and C2 C3? here

News-ID: 3790386 • Views:

More Releases from ABNewswire

Type 2 Diabetes Market to Expand Significantly by 2034, States DelveInsight Report | Eli Lilly and Company, Regor Pharma, AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova
Type 2 Diabetes Market to Expand Significantly by 2034, States DelveInsight Repo …
The Key Type 2 Diabetes Companies in the market include - Eli Lilly and Company, Regor Pharmaceuticals Inc., AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova, Sparrow Pharmaceuticals, HighTide Biopharma Pty Ltd, Novo Nordisk A/S, Biomea Fusion Inc., Altimmune, Inc., Novartis, Amgen, Neuraly, Inc., Carmot Therapeutics, Inc., Inventiva Pharma, Inversago Pharma Inc, Applied Therapeutics, Inc., and others. DelveInsight's "Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast-2034 report offers an
International Commercial Insurance brokerage confirmed as an Official Sponsor of
International Commercial Insurance brokerage confirmed as an Official Sponsor of …
Prepare for an electrifying fusion of technology, innovation, and entrepreneurial spirit! Investor, Author, and Entrepreneur, Ross Y. Dixon is supporting "AI & The Future of Entrepreneurship" Symposium, as one of the sponsors. The Dixon Agency, an international commercial insurance brokerage is excited to be on board. This groundbreaking event promises to equip aspiring entrepreneurs and future leaders with the revolutionary tools and cutting-edge knowledge necessary to thrive in an AI-driven world. This
Obesity Market Growth Projections 2024-2034: DelveInsight Analysis | Rhythm Pharmaceuticals, Boehringer Ingelheim, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharma, Caliway
Obesity Market Growth Projections 2024-2034: DelveInsight Analysis | Rhythm Phar …
The Key Obesity Companies in the market include - Rhythm Pharmaceuticals, Boehringer Ingelhium, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharmaceutical, Caliway Biopharmaceutics, Yuhan, Terns Pharmaceuticals, BioRestorative Therapies, SCOHIA PHARMA, Click Therapeutics, Hanmi Pharmaceuticals, Novo Nordisk, Empros Pharma, Carmot Therapeutics, Eli Lilly and Company, and others. DelveInsight's "Obesity Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Obesity, historical and forecasted epidemiology as well as the
Cell and Gene Therapies in Rare Disorders Market on Track for Major Expansion by 2034, According to DelveInsight | Pfizer, Sangamo Therapeutics, Orchard Therapeutics, SR-Tiget, Novartis, TVAX Biomed
Cell and Gene Therapies in Rare Disorders Market on Track for Major Expansion by …
The Key Cell and Gene Therapies in Rare Disorders Companies in the market include - Pfizer, Sangamo Therapeutics, Orchard Therapeutics/ SR-Tiget, Novartis, TVAX Biomedical, Aivita Biomedical, RHEACELL GmbH & Co, Capricor Therapeutics, and others. DelveInsight's "Cell and Gene Therapies in Rare Disorders Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cell and Gene Therapies in Rare Disorders, historical and forecasted epidemiology as well as the Cell

All 5 Releases


More Releases for A3/B4

Vitamin B4 Market is Going to Boom | Balchem, Eastman, BASF
The Latest research study released by HTF MI “Vitamin B4 Market - Global Outlook and Forecast Market” with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major
rint Management Solutions for A3 Multi-Function Printer (A3 MFP) Market global o …
The Global Print Management Solutions for A3 Multi-Function Printer (A3 MFP) Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Print Management Solutions for A3 Multi-Function Printer (A3 MFP) makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size,
A3 Multi-Function Printers (A3 MFP) Market global outlook and forecast 2021 -202 …
The Global A3 Multi-Function Printers (A3 MFP) Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a A3 Multi-Function Printers (A3 MFP) makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements. The report
Vitamin B4 Market Outlooks 2020: Industry Analysis, Market Segmentation, Challen …
The Global Vitamin B4 Market Report provides an in-depth analysis of the market by assessing the growth trends, products, applications, end-user segment, historical data, and information obtained through interviews of industry experts. This market intelligence report includes a comprehensive evaluation of the market, discussing the value, volume, size, share, growth rate, key trends, demand & supply ratio, gross revenue, competitive landscape, regional analysis, manufacturers, product types, and end-user applications to
H2 2017 Adenosine Receptor A3 (ADORA3)- Pipeline Review
"The Report Adenosine Receptor A3 (ADORA3)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" According to the recently published report Adenosine Receptor A3 (ADORA3)-Pipeline Review, H2 2017; Adenosine Receptor A3 (ADORA3) pipeline Target constitutes close to 18 molecules. Out of which approximately 16 molecules are developed by companies and remaining by the universities/institutes. Adenosine Receptor A3 (ADORA3)-The adenosine A3
Occupy The US Constitution Launched by A3 Society
Occupy Wall Street has another big task to do - fix the U.S. Constitution. The A3 Society, founded on breakthrough discoveries that EXACTLY address this task, has launched the National Opinion Collection System as a key component. Jacksonville, FL, January 08, 2012 - Occupy Wall Street has another big task to do - fix the U.S. Constitution. The A3 Society, founded on breakthrough discoveries that EXACTLY address this task, has launched